Term
|
Definition
undersurface
of
the
diaphragm
to
the
floor
of
the
pelvis
containing
the
stomach,
small
intestine,
large
intestine,
liver,
gallbladder,
and
spleen |
|
|
Term
|
Definition
duodenum,
pancreas,
kidneys,
adrenal
glands,
great
vessels
(aorta
and
vena
cava),
and
most
mesenteric
vascular
structures |
|
|
Term
|
Definition
| k.a. spontaneous bacterial peritonitis (SBP); inflammation of the peritoneum by an extraperitoneal source, frequently occurring from hematogenous dissemination; no evident source |
|
|
Term
|
Definition
| inflammation or mechanical break of the integrity of the intestinal or the urogenital tract or solid organs, thus exposing the peritoneal cavity to the resident GIT flora (e.g. acute peritonitis via perforation, postoperative peritonitis, or post-‐traumatic peritonitis) |
|
|
Term
|
Definition
associated with highest morbidity and mortality; persistent or recurrent 48 hrs after
intra-‐abdominal infection, after initial treatment of a primary or secondary peritonitis |
|
|
Term
| Primary peritonitis Microbiology |
|
Definition
| often always a monomicrobial infection caused by enteric gram negative rods |
|
|
Term
| Secondary and tertiary peritonitis Microbiology |
|
Definition
often a polymicrobial infection caused by enteric gram negative rods and
anaerobes |
|
|
Term
|
Definition
E coli
Escherichia coli
Klebsiella species
Pseudomonas aeruginosa 14
Proteus mirabilis
Enterobacter species |
|
|
Term
| Community-‐Acquired Empiric Combination Therapy Mild-‐Moderate |
|
Definition
1st generation: Cefazolin (IV)
2nd generation: Cefuroxime (IV/PO)
3rd generation: Ceftriaxone (IV), Cefotaxime (IV)
-‐Plus-‐ Metronidazole (IV/PO)
Ciprofloxacin (IV/PO), Levofloxacin (IV/PO)
-‐Plus-‐ Metronidazole (IV/PO) |
|
|
Term
| Community-‐Acquired Empiric Combination Therapy Severe |
|
Definition
3rd generation: Ceftazidime (IV)
4th generation: Cefepime (IV)
-‐Plus-‐ Metronidazole (IV/PO)
Ciprofloxacin (IV/PO), Levofloxacin (IV/PO)
-‐Plus-‐ Metronidazole (IV/PO)
Gentamicin (IV), Tobramycin (IV), Amikacin (IV)
-‐Plus-‐ Metronidazole (IV/PO) or Clindamycin$(IV/PO)
Aztreonam (IV)δ
-‐Plus-‐ Metronidazole (IV/PO) |
|
|
Term
| Community Acquired Empiric Monotherapy Mild-‐Moderate |
|
Definition
Amoxicillin/Clavulanate (PO)* Ampicillin/Sulbactam (IV/PO)* Ticarcillin/Clavulanate (IV)
2nd generation: Cefoxitin (IV)γ
Moxifloxicin (IV/PO)
Ertapenem (IV)
Tigecycline∝ (IV) |
|
|
Term
| Community Acquired Empiric Monotherapy Severe |
|
Definition
Piperacillin/Tazobactam (IV)
-‐
-‐
Imipenem/Cilastatin (IV) Doripenem (IV) Meropenem (IV)
-‐
Aztreonam (IV)δ
-‐Plus-‐ Metronidazole (IV/PO) |
|
|
Term
|
Definition
|
|
